Andranik Andrew Aprikyan

EVP, CSO and Co-Founder at Stemgenics, Inc

Andranik Andrew Aprikyan has had a diverse work experience. Andranik Andrew is currently an Affiliate Member at the Fred Hutchinson Cancer Research Center since 2020. Prior to that, they served as the EVP, CSO, and Co-Founder of Stemgenics, Inc from 2011 onwards. From 2009 to 2011, they held the position of Northwest Division Director at the National Collegiate Table Tennis Association (NCTTA). Andranik Andrew Aprikyan also had a significant role in coaching, as they served as the Head Coach of the University of Washington Women and Coed Table Tennis Teams from 2004 to 2011. Additionally, they worked as a Research Assistant Professor at the University of Washington from 1999 to 2010. Andranik Andrew Aprikyan started their career as a Senior Postdoctoral Research Fellow in the Hematology/Oncology division of the University of Washington in 1993, where they stayed until 1998.

Andranik Andrew Aprikyan has a diverse education history in the field of medical and biological sciences. Andranik Andrew obtained a PhD in Molecular Biology from the Engelhardt Institute of Molecular Biology, Academy of Sciences in Moscow, Russia. Prior to that, they completed their Master of Science (MS) degree in Protein Chemistry at Lomonosov Moscow State University (MSU). Andranik also holds a Bachelor of Science (BS) degree in Biophysics from Yerevan State University. Additionally, they attended High School Yerevan, which is not specified to have a specific degree or field of study. Andranik's most recent education affiliation is with the University of Washington - School of Medicine, where they specialize in Hematology/Oncology, although the specific timeframe is unknown.

Location

Seattle, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Stemgenics, Inc

Stemgenics is a developer of a technology that converts mature skin cells into personalized stem cells. The company's personalized stem cells may be used to regenerate any tissue of the human body.Stem cells can grow and develop into any cell type of the body. They are not rejected but are accepted by the body as its own cells. InStemgenics' breakthrough process, cells from a small patch of skin are placed in cell culture. Its patent-pending functionalized nanoparticles are added and the skin cells are reprogrammed into stem cells.


Employees

1-10

Links